We’re honored to be recognized on Forbes’ 2025 list of America’s Best Large Employers. This recognition highlights what we strive for every day—which is delivering on our mission to serve patients and fight some of the world’s toughest diseases.

At the Stanford Drug Discovery Symposium 2025, Amgen CEO Bob Bradway and EVP, R&D @JayBradner shared a compelling vision for the future of medicine. Swipe through our carousel for an exclusive look at what they had to say.

Now streaming! PsO Grateful Podcast Episode 2: Building PsOlidarity with your patients for Dermatology NPs and PAs. Hear seasoned PAs share strategies to foster open communication with patients about their plaque #psoriasis. Listen now: 🎙️. #PsOGrateful

This #VAM2025, staying quiet isn’t an option. 🗣️ . When it came to her care, Stacy didn’t wait for permission: she asked questions, pushed for answers, and built a care team that believed her. Her voice changed everything. Yours can too. Get inspired:

That’s a wrap! 🙌 The European Congress on Obesity gathered leading experts from around the world and organizations committed to improving the lives of people living with #obesity and related conditions– a mission we’re boldly dedicated to. #ECO2025 🔬🧬🤝.

RT @jaybradner: At the @MilkenInstitute Global Conference panel, we discussed how AI, genetics & protein engineering are transforming drug….

#ICYMI: Murielle and her team shared new preclinical research in mice around blocking GIPR and activating GLP-1R. 🧬🔬. 🔗Learn more in @NatMetabolism:

RT @POLITICOFocus: The introduction of biosimilars has already saved approximately $36 billion for the American health care system. Learn h….

This #VAM2025, we’re proud to spotlight the @VasculitisFound’s Community Heroes ❤️ . Their stories show the power of shared experience and the strength of the #vasculitis community. 🔗 Explore more here:

Amgen reports Q1 2025 earnings: . Safe Harbor: . $AMGN.

RT @RepBuddyCarter: We are bringing pharmaceutical manufacturing back to America. This is great news!. These are exactly the types of inves….

Amgen will report Q1 2025 financial results tomorrow. 🔗 Webcast info: . $AMGN

Amgen recently joined 10 biosimilar advocates for a roundtable co-hosted with @POLITICOFocus, exploring how to strengthen a competitive, sustainable US marketplace with #biosimilars and deliver more value for patients & the healthcare system. Learn More:

Today, @NatMetabolism published new preclinical research in mice around blocking GIPR and activating GLP-1R. 🧬🔬. This study was led by @DanielJDrucker, Endocrinologist and Professor at @UofT, and Murielle Véniant-Ellison, Scientific VP at Amgen leading #obesity research. 🔗

Amgen will report Q1 2025 financial results on Thursday, May 1. 🔗 Details here: . $AMGN

Developing innovative options for people with #obesity and related conditions drives our team. 🔬. We attended #OM25 to connect with advocacy & other healthcare leaders on how we can advance patient care. #ObesityMedicine2025. 🔗 Learn more: